Delivery Order SPE2DB22D2211-SPE2DB25FSEFD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,606.41. This is a firm fixed-price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100-count bottles) with a ceiling value of $1,234.72. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) on August 5, 2025, with a ceiling value of $2,111.70 and an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dexmethylphenidate Extended Release 10 mg capsules (100-count bottles) with a ceiling value of $1,433.11. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively evaluated. The ultimate completion date is August 22, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100-count units) with a ceiling value of $10,245.76. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The performance location is established at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count bottles) with a contract ceiling value of $1,772.16. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,148.65. This non-competitive, firm fixed-price delivery order is set to conclude on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for dexmethylphenidate ER 25 mg capsules (100-count) on August 20, 2025, with a ceiling value of $1,011.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is structured as a child contract under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEFDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of dexmethylphenidate ER 15 mg capsules (100-count bottles) with a ceiling value of $1,444.29. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is a child contract issued against AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supply vendor through its extensive contract portfolio with the Defense Logistics Agency. The company's comprehensive IDC vehicle supports military healthcare systems globally, enabling the delivery of a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for dexmethylphenidate reflects the company's role in supplying neurological and psychopharmacological medications essential to Defense Health Agency and military medical operations. The rapid completion timeline from award to delivery indicates the responsive nature of the standing IDC framework for urgent pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/4/25 |